MI192 induced epigenetic reprogramming enhances the therapeutic efficacy of human bone marrows stromal cells for bone regeneration

Man, K, Mekhileri, NV, Lim, KS et al. (3 more authors) (2021) MI192 induced epigenetic reprogramming enhances the therapeutic efficacy of human bone marrows stromal cells for bone regeneration. Bone, 153. 116138. ISSN 8756-3282

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2021 Elsevier Inc. All rights reserved. This is an author produced version of an article published in Bone. Uploaded in accordance with the publisher's self-archiving policy.

Keywords: HDAC inhibitor; Histone deacetylase; Osteogenic differentiation; MI192; Bone marrow stromal cells; Bone tissue engineering; Epigenetics; Additive manufacturing
Dates:
  • Published: December 2021
  • Published (online): 31 July 2021
  • Accepted: 27 July 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Dentistry (Leeds) > Oral Biology (Leeds)
Funding Information:
Funder
Grant number
Changzhou Kanghui Medical Innovation Co
No Ext Ref Given
EU - European Union
318553
Depositing User: Symplectic Publications
Date Deposited: 13 Aug 2021 09:57
Last Modified: 31 Jul 2022 00:13
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.bone.2021.116138
Open Archives Initiative ID (OAI ID):

Export

Statistics